As of March 2026 NervGen Pharma has a market cap of A$0.43 Billion. This makes NervGen Pharma the world's 7906th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.